This company seems to have been delisted
Reason: Acquired by Assertio Holdings
Last recorded trade on: October 3, 2023
Source: https://investor.sppirx.com/news-releases/news-release-details/assertio-holdings-inc-acquire-spectrum-pharmaceuticals-inc-all
Reason: Acquired by Assertio Holdings
Last recorded trade on: October 3, 2023
Source: https://investor.sppirx.com/news-releases/news-release-details/assertio-holdings-inc-acquire-spectrum-pharmaceuticals-inc-all
Spectrum Pharmaceuticals
SPPI
C$1.41
Share price
0.00%
Change (1 day)
16.83%
Change (1 year)
Categories
Spectrum Pharmaceuticals (SPPI) - Total debt
Total debt on the balance sheet as of March 2023 : C$39.36 Million
According to Spectrum Pharmaceuticals 's latest financial reports the company's total debt is C$39.36 Million. A company’s total debt is the sum of all current and non-current debts.
Spectrum Pharmaceuticals - Total debt on balance sheet (from 1996 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | C$38.89 M | 2280.8% |
| 2021-12-31 | C$1.63 M | -17.01% |
| 2020-12-31 | C$1.96 M | -62.83% |
| 2019-12-31 | C$5.29 M | |
| 2017-12-31 | C$48.05 M | -63.15% |
| 2016-12-31 | C$0.13 B | -7.42% |
| 2015-12-31 | C$0.14 B | 26.05% |
| 2014-12-31 | C$0.11 B | 14.76% |
| 2013-12-31 | C$97.38 M | 30.57% |
| 2012-12-31 | C$74.58 M | 23782.38% |
| 2011-12-31 | C$0.31 M | 681.01% |
| 2010-12-31 | C$0.03 M | -44.93% |
| 2009-12-31 | C$0.07 M | -99.21% |
| 2008-12-31 | C$9.23 M | |
| 2003-12-31 | C$0.18 M | -74.34% |
| 2002-12-31 | C$0.73 M | -63.29% |
| 2001-12-31 | C$1.99 M | -17.22% |
| 2000-12-31 | C$2.41 M | 0.26% |
| 1999-12-31 | C$2.4 M | 4.35% |
| 1998-12-31 | C$2.3 M | 7.61% |
| 1997-12-31 | C$2.14 M | 160.79% |
| 1996-12-31 | C$0.82 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Teva Pharmaceutical Industries TEVA | C$23.12 B | 58,634.40% | 🇮🇱 Israel |
 Seagen
SGEN | C$0.15 B | 293.51% | 🇺🇸 USA |
 Curis CRIS | C$3.6 M | -90.85% | 🇺🇸 USA |
 Biogen BIIB | C$9.03 B | 22,858.39% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | C$69.94 B | 177,566.44% | 🇺🇸 USA |
 Abbott Laboratories ABT | C$18.07 B | 45,815.40% | 🇺🇸 USA |
 Novartis NVS | C$42.68 B | 108,325.80% | 🇨🇭 Switzerland |
 Johnson & Johnson JNJ | C$71.32 B | 181,078.92% | 🇺🇸 USA |
 Pfizer PFE | C$83.66 B | 212,420.80% | 🇺🇸 USA |
 GlaxoSmithKline GSK | C$32.51 B | 82,479.06% | 🇬🇧 UK |